# Metagenomi (MGX) — Earnings

MGX · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/mgx/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2025 |
| Period end | Jun 30, 2025 |
| EPS actual | −$0.54 |
| EPS estimate | −$0.62 |
| EPS surprise | +12.76% |
| Revenue surprise | +0.69% |
| Revenue | $8.5M |
| Revenue estimate | $8.5M |
| Reported | Aug 12, 2025 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1785279/000095017025107308/mgx-20250630.htm) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2025 | Aug 12, 2025 | −$0.62 | −$0.54 | 12.76% | $8.5M | $8.5M |
| Q1 2025 | May 13, 2025 | −$0.61 | −$0.68 | -11.75% | $8.3M | $4.1M |
| Q4 2024 | Mar 17, 2025 | −$0.75 | −$0.37 | 50.59% | $9.2M | $9.6M |
| Q2 2024 | Aug 14, 2024 | −$0.65 | −$0.29 | 55.62% | $12.7M | $20.0M |

## Frequently Asked Questions

### When did Metagenomi (MGX) last report earnings?

Metagenomi last reported on Aug 12, 2025, covering fiscal Q2 2025.

### Did MGX beat earnings estimates?

Yes. Metagenomi reported EPS of −$0.54 for Q2 2025 against a −$0.62 estimate — a 12.76% beat.

### How much revenue did MGX report last quarter?

Metagenomi reported $8.5M in revenue for Q2 2025, against a consensus estimate of $8.5M.

## Similar Stocks

- [MRNA](https://www.lighthorse.io/tickers/mrna) — Moderna, Inc. - Common Stock

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).